Vaxcyte, Inc. (PCVX) stock analysis

In our weekly check, Vaxcyte, Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 4 pass, warnings: 3, red flags: 11.

About Vaxcyte, Inc.

Vaxcyte, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PCVX.

What our checks show for PCVX

Red flags

Warning signs

Strengths

Similar companies

MDGL · SYRE · TGTX · KYMR · PRAX · BMRN

Questions

What grade does Vaxcyte, Inc. (PCVX) have?

In our weekly check, Vaxcyte, Inc. is graded F (A to F). Of 18 checks on debt, profit, cash flow and trend: 4 pass, warnings: 3, red flags: 11. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of PCVX stock?

This week's biggest flags for Vaxcyte, Inc.: High debt, Weak EPS forecast, Margins expected to shrink. In total 14 of 18 checks show a warning or a red flag.

What does Vaxcyte, Inc. do?

Vaxcyte, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PCVX.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis